MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

15 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer

08 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

03 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

01 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

18 Sep 2024 10:03:42 By NetDania Notify

Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference

18 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics to Host Investor Event on October 9, 2024

05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

29 Aug 2024 12:31:27 By NetDania Notify

Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

21 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

06 Aug 2024 15:05:01 By Nasdaq GlobeNewswire

Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific

01 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer

31 Jul 2024 07:50:00 By Nasdaq GlobeNewswire

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

30 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

24 Jul 2024 09:17:07 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

23 Jul 2024 09:02:36 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

22 Jul 2024 12:44:46 By NetDania Notify

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

17 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

16 Jul 2024 08:46:09 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

15 Jul 2024 08:45:02 By NetDania Notify